ACCESS to innovation.
A new path to POSSIBILITY.
Personalized Neoantigen Vaccines through Compassionate Access
The Jaime Leandro Foundation (JLF) is a private nonprofit organization established to deliver breakthrough cancer treatments. We are a unique consortium of experts in cancer, personalized medicine, clinical trials, and vaccines working to provide access to personalized cancer vaccines through clinical trials and by leveraging the FDA’s Expanded Access rule. Learn more.
For Patients & Families
You or someone you love has been diagnosed with an aggressive form of cancer. Conventional medicine—the “standard of care”—offers little or no hope. We provide new access to treatment options.
For Physicians
You have a patient with a life-threatening condition who might benefit from a personalized vaccine if one could be developed. We can facilitate the process.
Leadership Team
-
![]()
William Hoos
President
Jaime Leandro Foundation
-
![]()
Marty Tenenbaum
Co-founder & Chairman
xCures and Cancer Commons
-
![]()
Andrew Jacobs
Board Member
noRD Bio, Inc.
-
![]()
William Gillanders, MD
Professor of Surgery, Vice Chair Research
Washington University School of Medicine in St. Louis
-
![]()
Malachi Griffth, PhD
Professor
Washington University School of Medicine in St. Louis
-
![]()
Jason Chang
CEO
CSBio
